Exosome Test for Detection of Pancreatic Cancer

Pancreatic Cancer Detection Consortium

Recruiting Observational Study
Pancreatic Cancer Pancreatic Carcinoma Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Neoplasms Pancreatic Cancer Stage I Pancreatic Cancer Stage Pancreatic Cancer Resectable Pancreatic Cancer Stage 0 Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer, Adult Pancreatic Cancer Non-resectable
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
City of Hope Medical Center · Other
Who this trial is looking for

This trial is looking for people with pancreatic cancer to help test a new way to detect the disease early using a blood sample. Participants will need to have been diagnosed with pancreatic ductal adenocarcinoma and have had tests done to confirm their condition before any treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with pancreatic ductal adenocarcinoma
  • I am at stage I-IV of the disease
  • I have had standard diagnostic tests as per local guidelines
  • I had a sample taken before starting any curative treatment
  • I have proof from imaging or endoscopy that I do not have the disease at the time of sampling

You may not be able to join if

  • I have not given written consent to participate in the trial

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition) * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment. * Imaging-…
Contacts

Ajay Goel, PhD

6262183452

AJGOEL@COH.ORG

CONTACT